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Graphical Abstract 
 
 
Highlights  
 
 Toxicological relevant effects on post-natal development in female mice were 
observed after dietary exposure to HBCD, CB-153, or TCDD at doses below 
previously established effect levels  
 Histopathological changes were found in liver (HBCD, CB-153, TCDD), thymus 
(HBCD, CB-153) and uterus (HBCD) 
 HBCD, CB-153 and TCDD all caused alterations of protein and gene expression in 
the brain  
 Effects on sex steroid signalling and serum levels were seen in response to HBCD or 
CB-153  
 Genes involved in Ca2+ and Zn2+ signalling and in neurological disease were 
regulated by all three toxicants 
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Abstract  
Developmental health risks of chronical exposure to low doses of foodborne persistent 
organic pollutants (POP) are recognized but still largely uncharacterized. Juvenile female 
BALB/c mice exposed to either HBCD, CB-153 or TCDD at doses relevant to human 
dietary exposures (49.5 μg, 1.35 μg and 0.90 pg kg-1 bw-1 day-1 , respectively) for 28 days 
displayed histopathological changes in liver (HBCD, CB-153, TCDD), thymus (HBCD, 
CB-153) and uterus (HBCD), reduced serum oestradiol 17β (E2) levels (HBCD), increased 
serum testosterone (T) levels (CB-153) and an increased T/E2 ratio (HBCD). Proteomics 
analysis of brain provided molecular support for the HBCD-induced reduction in E2. Neural 
gene expression analysis, confirmed effects on 18 out of 30 genes previously found to 
affected after exposure to higher doses to the same pollutants. Our findings indicate that 
exposure to POP at low doses is associated with subtle, but toxicological relevant effects on 
post-natal development in female mice. 
Abbreviations 
ACTB actin, beta 
AhR aryl hydrocarbon receptor  
AHR  activation of the Aryl Hydrocarbon Receptor  
Arnt aryl-hydrocarbon receptor nuclear translocator 2  
Arntl  aryl hydrocarbon receptor nuclear translocator-like  
ARPC2 actin-related protein 2/3 complex subunit 2  
ATP5B ATP synthase, H+ transporting, mitochondrial F1 complex, beta 
polypeptide 
BBB blood brain barrier 
BFR brominated flame retardants  
BFR brominated flame retardants  
BVA Biological Variation Analysis 
Ca2+  calcium  
CAR  constitutively active/androstane receptor  
CB-153 2,4,5,2',4',5'-hexachlorobiphenyl 
CYP cytochrome P450  
DIA Differential In-Gel Analysis  
DIGE difference in gel electrophoresis  
DL  dioxin like  
Dnajb5 DnaJ Hsp40) homolog, subfamily B, member 5 
DNM1 dynamin 1  
DPYSL3  dihydropyrimidinase-related protein 3  
E2  17ß-oestradiol  
Eapp E2F-associated phosphoprotein  
EFSA European Food Safety Authority  
Eif5 eukaryotic translation initiation factor 5  
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emPAI exponentially modified protein abundance indice 
ENO1 alpha-enolase  
EU European Union’s  
G6PD and glucose-6-phosphate dehydrogenase  
GAPDH glyceraldehyde-3-phosphate dehydrogenase  
HBCD 1,2,5,6,9,10-Hexabromocyclododecane  
HD high dose  
HSPA8 heat shock 70kDa protein 8  
Hspa8 heat shock 70kDa protein 8  
IEF Isoelectric focusing 
IPA  Ingenuity Pathway Analysis  
IVD isovaleryl-CoA dehydrogenase, mitochondrial 
JECFA  Joint FAO/WHO Expert Committee on Food Additives 
LC-MS/MS Liquid chromatography tandem mass spectrometry  
LD low dose  
LOAEL  lowest observed adverse effect levels  
Lztfl1 leucine zipper transcription factor-like 1  
MAPK14 mitogen-activated protein kinase 14  
MOE margin of exposure  
Mterfd2 mitochondrial transcription termination factor 4  
Mtf1 metal-regulatory transcription factor 1  
NDL  non-dioxin like  
NfkB nuclear factor kappa B  
NOAEL  no observed adverse effect level  
Nr1i3 nuclear receptor subfamily 1, group I, member 3 
Nsdhl NAD P) dependent steroid dehydrogenase-like  
PCBs polychlorinated biphenyls  
Pnkd  paroxysmal nonkinesigenic dyskinesia  
POP persistent organic pollutants  
PXR pregnane X receptor  
qPCR quantitative polymerase chain reactions  
RALA v-ral simian leukemia viral oncogene homolog A ras related 
SCF European Commission's former Scientific Committee for Food  
SIRT2 NAD-dependent deacetylase sirtuin-2  
Slc30a3 solute carrier family 30 zinc transporter), member 3 
Sphk2 sphingosine kinase 2  
Srrm2 serine/arginine repetitive matrix 2  
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T Testosterone  
T/E2 - ratio  Testosterone/17ß-oestradiol ratio  
Tarsl2 threonyl-tRNA synthetase-like 2 
TCDD 2,3,7,8-tetrachlordibenzo-p-dioxin 
TEQWHO toxic equivalency quotient  
Tnfsf12  tumor necrosis factor ligand) superfamily, member 12 
TUB2A tubulin beta-2A chain  
TWI  tolerable weekly intake  
US EPA  United States Environmental Protection Agency  
Zn2+  zinc  
 
 
Keywords: POP; endocrine disruption; neurotoxicity; calcium; zinc; G6PD; oestradiol; 
liver 
 
1. Introduction 
Persistent organic pollutants (POP) are bioaccumulating and biomagnifying 
environmental contaminants that resist degradation in the environment and are a major 
concern to human health [1].  
The Brominated flame retardant (BFR) 1,2,5,6,9,10-Hexabromocyclododecane (HBCD) 
has become a ubiquitous environmental contaminant and is detected at increasing levels in 
human adipose tissue, serum, breast milk and human fetal tissue [2]. Due to its adverse effects 
on human health and the environment, HBCD has been listed under the Stockholm 
convention on POP in Annex A (POP for elimination) with the specific exceptions that 
HBCD can be still produced and used for expanded polystyrene and extruded polystyrene in 
buildings [3]; thus, environmental exposure to HBCD is likely to persist. Among population 
subgroups within the EU, children (3-10 years old) have been reported to have the highest 
intake of HBCD [4]. Knowledge of the toxicodynamics of HBCD has increased in recent 
years, but is still limited [5]. HBCD can cause histological damage to liver, thymus and 
thyroid, and adversely affect thyroid hormone levels and thyroid hormone receptor-mediated 
gene expression [4,6–8]. In a combined in vivo and in vitro transcriptomics study in mice, 
the hypothalamus-hypophysis-gonadal axis was a major target of HBCD exposure [3]. 
Accordingly, reproductive toxicity of HBCD has been reported in both male and female rats 
[4,9]. HBCD has effects on memory and learning [6,10], which may be caused by impaired 
dopamine and glutamate re-uptake, and disruption of calcium (Ca2+) and zinc (Zn2+) 
signalling in glutamatergic neurons [3,11,12]. Neurodevelopmental effects on behaviour in 
mice was selected as the critical effect by the European Food Safety Authority (EFSA) in 
their risk assessment on HBCD [4]. 
The polychlorinated biphenyl (PCB) 2,4,5,2',4',5'-hexachlorobiphenyl (CB-153) was 
shown to induce adverse effects in a number of target tissues including the thyroids, 
reproductive system, liver and brain [13]. CB-153 may affect biological systems through 
mechanisms including disruption of cellular Ca2+ homeostasis [14], and activation of both 
the constitutively active/androstane receptor (CAR) and the pregnane X receptor (PXR) [15]. 
For CB-153, EFSA established a no observed adverse effect level (NOAEL) of 1.2 mg kg-1 
bw d-1, based on hepatotoxicity in rats as the critical effect [13]. More recently, based on 28 
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and 90 days repeated dose exposure studies, the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) estimated the NOAEL for effects on liver and thyroid for CB-153 to be 
10 µg kg-1 bw d-1 and calculated an estimated margin of exposure (MOE) of 1600 - 3100 for 
adults [16]. Other health based guidance values such as a tolerable weekly intake (TWI) for 
CB-153 are, due to a general lack of in vivo toxicity data, yet to be established [13,16].  
Dioxins including as 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD) and dioxin-like (DL) 
PCBs are thoroughly investigated POP with targets of toxicity including the reproductive and 
the immune system [17] as well as the brain, affecting neurodevelopment, cognitive faculties 
and motor function [18–20]. Dioxins exert toxicity through binding to and activation of the 
Aryl Hydrocarbon Receptor (AHR) [21], which controls a large battery of genes including 
members of the cytochrome P450 (CYP) family [22], the nuclear factor kappa B (NfkB)  [23] 
and sex steroid receptors [24,25]. The European Commission's former Scientific Committee 
for Food (SCF) established a LOAEL for TCDD of 25 ng kg-1 bw d-1 based on reproductive 
toxicity after subcutaneous exposure in rats and established a TWI for dioxins and DL PCB 
of 14 pg kg-1 bw d-1 [26]. More recently, the United States Environmental Protection Agency 
(US EPA) set a reference dose which was three-fold lower than the TWI established by the 
SCF. Currently, EFSA is in the process of re-evaluating and updating the health based 
guidance value for dioxins and DL PCBs [27]. 
Exposure to POP during childhood is considered of particular importance as the 
developing organism for the first time experiences direct exposure to contaminants in the 
environment and the diet without the mediation of maternal metabolism occurring in 
pregnancy or lactation [28]. Due to the specific vulnerability and susceptibility of this life 
stage, children may thus experience greater risks from exposure compared to adults [29]. 
Using a rodent juvenile model of toxicity our team previously assessed endocrine and 
histological changes in multiple organs alongside transcriptomic and proteomic responses 
following dietary exposure to HBCD, CB-153 or TCDD at doses close to their respective 
lowest observed adverse effect levels (LOAEL) in mice [7,18]. We found adverse effects on 
livers, thyroid and immune system and altered sex steroid balance [7]. We also found that 
these POP accumulate in the juvenile brain where TCDD and HBCD caused dysregulation 
of the otherwise tightly controlled homeostasis of Ca2+ and Zn2+ [3,18].  
While the aforementioned work was done appropriately for the study of dietary early life 
exposure [30], the concentrations of HBCD, CB-153 and TCDD used in the experimental 
diets were much higher than the levels usually detected food. In the present work, we assessed 
systemic responses observed in the same juvenile toxicity model after 28-day repeated dose 
exposure to dietary relevant concentrations of HBCD, CB-153 and TCDD. Based on the 
findings from our previous study, which we carried out at approximately 100 (CB-153 and 
TCDD) to 4000-fold (HBCD) higher doses but otherwise under identical conditions, we paid 
special attention to endocrine disruption and neurotoxicological effects in developing female 
juvenile BALB/c mice. 
 
2. Materials and Methods  
2.1 Animals  
To assess the toxicity of environmentally realistic doses of HBCD, CB-153 and TCDD 
an animal exposure experiment was conducted at King’s College London (KCL) in 
accordance with the project license guidelines (PPL70/6407) granted under the UK Home 
Office Animals (Scientific Procedures) Act, 1986. The experimental protocol for juvenile 
toxicity studies was performed as described in [7,18]. In short, 40 22-day old female BALB/c 
mice (average weight 13 to 15 g) purchased from Charles River (UK) were housed in 
Utemp1284 mouse cages (Tecniplast, UK) with wood chips bedding (Aspen-wood chips, B 
AC
CE
PT
ED
 M
AN
US
CR
I T
  
and K Ltd) in rooms controlled for temperature (20 °C to 22 °C), relative humidity (45 % to 
65 %), and lighting (12 hour light/dark cycle). After an acclimation period of three days, mice 
were allocated at random into experimental diet groups. Mice were provided with water ad 
libitum but feed intake was restricted to 15 % (w/w) kg-1 bw day-1 to provide for an animal 
model, which more closely resembles dietary intake of healthy human individuals [31–33]. 
Throughout the feeding experiment, the general health status of mice was assessed daily and 
food consumption and body weight gain were recorded weekly and are presented as means 
± Standard Deviation (SD). Differences among groups were determined by one-way 
ANOVA using GraphPad Prism (GraphPad, US). In accordance with Home Office regulation 
for use of animals in research, we used as few animals as possible to obtain the required 
results and the number of animals in each group was based on results from previous 
experiments [7, 18]. Because of loss of tissue for some analyses all analyses did not have the 
same number of biological replicates and the number of animals used for each analysis has 
been summarised in Table S1. 
 
2.2 Experimental diets 
To closely reflect human exposure to the model POP through marine food sources, 
which are major contributors to HBCD, CB-153 and TCDD exposure, fish-based 
experimental diets were prepared as previously described [7,18,34]. In brief, diets were 
formulated in accordance with the standard rodent diet formulation AIN-93 G and divided 
into four equal parts of which one part was used as control. The remaining three parts of the 
diet were spiked with 10 ng g-1 CB-153, 335 ng g-1 HBCD and 6 pg g-1 2,3,7,8-TCDD, 
respectively. Prior to the start of the animal experiment, the diets produced were analysed for 
their contaminant content as described by Maranghi et al. [7].  
 
2.3 Rationale for dose selection 
Using the same fish based diets as vehicles, our group previously described the effects of 
HBCD, CB-153 and TCDD at their respective LOAELs of 199 mg kg-1 bw day-1, 195 μg kg-
1 bw day-1 kg-1 bw day-1 and 90 ng kg-1 bw day-1 [7,18]. In the present work, juvenile female 
BALB/c mice from the same cohort were exposed to diets spiked with 334.64 ± 79.21 ng g-
1 HBCD, 10.13 ±0.81 ng g-1 CB-153 and 6.06 ±0.49 pg g-1 TCDD. The selected concentration 
of HBCD lies within the range of concentrations detected in fish caught in urban Europe, 
which range from 10 to 1000 ng g-1 [35]. The concentration of CB-153 is comparable with 
levels detected in fatty fish from the Baltic Sea, which were found to contain up to 1.6 ng 
CB-153 g-1 wet weight [13]. The concentration of TCDD in the feed corresponds to the 
highest mean levels of dioxins detected in eels, 6.7 pg TEQWHO98 g-1 wet weight [36].  
 
2.4 Tissue sampling and processing 
Tissue sampling and processing were performed as previously described [7,18]. In short, 
after 28 days of exposure, mice were anaesthetised with Isoflurane (5% mix with oxygen) 
and placed under an anaesthetic delivery mask. Blood was collected by cardiac puncture; 
then the anaesthetised animals were sacrificed by cervical dislocation. Brain, liver, spleen, 
thymus, thyroid and uterus were sampled and weighed. Following dissection and necropsy, 
left cortices of the brain were flash-frozen in liquid nitrogen, ground in a liquid nitrogen 
cooled mortar and pestle and processed further as protein and gene extraction methods 
dictated. Right cortices of the brain and all other tissue samples were fixed in 10% (v/v) 
buffered formalin and following storage in 80% ethyl alcohol embedded in paraffin prior to 
histological and histomorphometrical analyses. Differences among groups were assessed by 
one-way ANOVA using GraphPad Prism (GraphPad, US). 
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2.5 Histological, and histomorphometrical analyses  
Histological and histomorphometrical analyses were performed as previously described 
[7]. In short, paraffin embedded tissues were cut into 5 µm sections and stained the specimens 
with haematoxylin and eosin for examination under a light microscope (Nikon Microphot 
FX) with different lenses. Thyroid, adrenals, spleen, thymus and uterus also were subjected 
to quantitative histomorphometrical analysis. Briefly, slides of selected tissues were 
examined by using an image analysis system (Nis-Elements D) applied to an optical 
microscope (Nikon Microphot FX). For the uterus, the ratio between the area of endometrium 
and myometrium as relative percentage of both uterine tissue components were determined. 
For thyroids, the follicular density, as ratio between number of follicles and a predetermined 
thyroid area was determined. In addition, indirect follicular cell height as the mean ratio of 
follicle and colloid area in five randomly selected follicles/sample was assessed. In the same 
follicles, the mean ratio of follicular epithelium areas and number of nuclei were calculated 
as an indicator of follicular maturation. Follicular cell height was estimated as the mean of 
five cell heights in five randomly selected follicles/sample. For adrenals the ratio between 
area of cortex and medulla was calculated. For the thymus the ratio between area of cortex 
and medulla was calculated and for the spleen the ratio between red pulp and white pulp areas 
was determined.  
Histological data are presented as proportions of quantal data (% presence) and analysed 
by pairwise comparisons of treated groups with control group by means of two-tailed Fisher 
Exact Test. Histomorphometrical data (mean ± SD) were analysed by the Mann Whitney U-
test. We considered differences between groups significant at the p ≤ 0.05 level. 
 
2.6 Hormone measurements 
Steroid hormone analysis was performed as described by Maranghi et al. [7]. In short, 
serum for the analysis of Testosterone (T) and oestradiol 17β (E2) levels was obtained 
through centrifugation of coagulated blood samples. Serum levels were measured using 
radioimmunoassay kits (DPC-coat-a-count Total Testosterone kit and DSL-4400 Oestradiol 
RIA kit). Hormone data are presented as means ± SD and differences among groups were 
assessed by one-way ANOVA using GraphPad Prism (GraphPad, US).  
 
2.7 Protein extraction and quantitative intact proteomics analysis 
Protein extraction and quantitative intact proteomics analysis were performed as 
described by Rasinger et al. 2014 [18]. In brief, proteins were extracted using the Sample 
Grinding Kit with a standard 2 x DIGE Lysis Buffer. Lipids and nucleic acids were removed 
from the samples using acetone precipitation and protein pellets were re-suspended in DIGE 
Labeling Buffer. Following protein quantitation (2D Quant Kit) control (n=6), CB-153 (n=6), 
HBCD (n=6) and TCDD (n=6) treated samples were labelled with 200 pmol fluorescent 
cyanine dyes using the minimal CyDyeTM DIGE Fluors Cy3 and Cy5 in a symmetrical dye-
swap design. In addition, we mixed excess control (n=6) and treated (n=24) samples in a 1:1 
ratio to produce internal standard (IS). IS was Cy2TM (CyDyeTM DIGE Fluor) labelled for 
DIGE and used in bulk on preparative gels, respectively. Randomly selected Cy3 and Cy5 
labeled samples were combined with Cy2TM labeled IS and cup-loaded onto IPG strips. 
Isoelectric focusing (IEF) was performed on an IPG Phor II run at 75 µA/IPG strip for 60 
kVh at 20 ºC. Upon completion of the IEF, equilibrated IPG strips were subjected to 
polyacrylamide gel electrophoresis using using polyacrylamide gels cast in house. Following 
the electrophoretic separation of the CyDyeTM – labeled proteins, we imaged the gels 
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immediately using an Ettan DIGE Imager. Aquired images were subjected to data analyses 
using the DeCyderTM 2D, the BioConductor package Limma and the Qlucore Omics 
Explorer. Only protein spots were considered for mass spectrometry (MS) identification that 
were identified as differentially expressed at the p<0.01 level in at least two of the three 
statistical analyses performed. In addition, we also identified a subset of proteins significant 
at p<0.05 to facilitate pathway analysis and to allow for validation of Ingenuity Pathway 
Analysis (IPA) predicted changes in the expression data set.  
 
2.8 Protein mass spectrometry and proteomics bioinformatics analysis 
Protein MS and proteomics bioinformatics analysis was performed as described by 
Rasinger et al. [18]. In brief, gel spots containing the differentially expressed proteins were 
excised from preparative 2D gels and digested with sequencing grade trypsin using an 
Investigator ProGest robotic digestion system [37,38]. Tryptic peptides were separated by 
reverse phase nano-flow liquid chromatography and subjected to online tandem mass 
spectrometry analysis via a nano-spray source. Spectra were collected from the mass analyser 
using full ion scan mode over the m/z range 450 - 1600. Six dependent tandem MS (MS/MS) 
scans were performed on each ion using dynamic exclusion. The obtained MS/MS data were 
matched to database entries using the SEQUEST algorithm in Bioworks and then exported 
the data to Scaffold. Carboxyamidomethylation of cysteine was used as a fixed modification, 
and oxidation of methionine was used as a variable modification. The mass tolerance was set 
at 10 ppm for the precursor ions and at 1 AMU for fragment ions. Two missed cleavage sites 
were allowed. We loaded search results into Scaffold software where protein and peptide 
probabilities were computed. Assignments were accepted with > 99.0% protein probability, 
> 95.0% peptide probability, and a minimum of two peptides [39,40]. If we detected co-
migration of proteins in one single spot exponentially modified protein abundance indices 
(emPAI) [41] as implemented in Mascot were calculated to determine the relative abundance 
of each protein present in the spot. The search settings we used in the Mascot were identical 
to ones used in Bioworks described above. Biological network analysis was performed to 
concomitantly interpret the proteomics data. Uniprot-Swissprot Accession numbers of 
identified differentially expressed (p<0.05) proteins were uploaded into the Ingenuity 
Pathway Analysis software suite (IPA, Ingenuity Systems, USA). Successfully mapped 
proteins were subjected to an IPA Core Analysis using default settings followed by targeted 
upstream regulator analysis. 
 
2.9 RNA extraction and qPCR analysis 
Total RNA was extracted from the brain using Trizol (Invitrogen, Life Technologies, USA) 
and the Qiagen RNeasy-Mini kit (Qiagen, Canada). RNA purity was assessed using a 
Nanodrop ND-100 UV-Vis Spectrophotometer (Nanodrop Technologies, USA) and RNA 
quality and integrity using the Agilent 2100 Bioanalyzer in combination with the RNA 6000 
LabChip kit (Agilent Technologies, USA). Expression levels of mRNA were measured by 
quantitative polymerase chain reactions (qPCR) on an ABI Prism7900 instrument, using 
either SYBR green or hydrolysis probe assays. cDNA was synthesised from 5 µg of total 
RNA using random primers and SuperScript™ III (Invitrogen). Following cDNA synthesis 
and RNA degradation by RNase H, cDNA was stored at -20°C until used. The GeNorm 
mouse housekeeper selection kit was used (Primerdesign) and cytoplasmic beta actin 
(ACTB) identified as the least variable transcript among six candidates in 15 randomly 
selected samples covering exposure to each of the four POP. qPCR experiments were run for 
31 gene targets deploying pre-validated assays (Roch Diagnostics) based on Universal 
ProbeLibrary (UPL) short hydrolysis probes, substituted with locked nucleic acids. Samples 
from five animals per condition were analysed in quadruplicate technical replicates for each 
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of the 31 transcripts and for the housekeeping gene ACTB. Expression of transcripts analysed 
using UPL was statistically assessed using pairwise comparisons of dCt (cycle threshold 
target – cycle threshold HKG) values against the control group with the Qlucore Omics 
Explorer software (Qlucore, Sweden). In all cases, the data were expressed as fold-change 
(FC) relative to the control group with statistical significance (ANOVA) accepted at p<0.01 
and p<0.05. 
 
3. Results 
3.1 Chemical analysis, general observations and necropsy findings 
Juvenile female BALB/c mice fed the: (i) HBCD spiked diet (334.64 ± 79.21 ng HBCD 
g-1) were exposed to 49.5 μg HBCD kg-1 bw-1 day-1; (ii) mice fed the CB-153 spiked diet 
(10.13 ±0.81 ng g-1) to 1.35 μg CB-153 kg-1 bw-1, and (iii) mice fed the TCDD spiked diet 
(6.06 ±0.49 pg g-1) to 0.90 pg TCDD kg-1 bw-1. During exposure, we recorded no differences 
in feed consumption or weight gain. No effects were observed at the time of sampling 
concerning final body weight, target organ weights, somatic indices of the liver, spleen or 
thymus; no gross lesions or other treatment-related changes were observed at necropsy. 
 
3.2 Histopathological findings and hormone measurements 
In mice exposed to HBCD the livers showed significantly (p<0.05) increased 
vacuolation in hepatocytes (62%), lymphocytic infiltration (+75%), and hyperaemic vessels 
(+75%); in addition, the thymus showed significantly (p<0.05) increased signs of tissue stress 
(+50%) and the uterus a significant increase of the incidence of reduced density of 
endometrial glands (Table 1). Follicles with larger cells were present in the thyroid, as shown 
by a significantly increased (p <0.05) ratio between follicular epithelium areas and number 
of nuclei (+20%) (Table 2). No significant effects on histology were observed in adrenals, 
brain and spleen. In the HBCD-exposed group the serum concentration of oestradiol 17β was 
significantly (p<0.05) lower and the testosterone to oestradiol 17β ratio (T/E2 - ratio) was 
significantly (p<0.05) higher than the control group (Figure 1).  
In the animals exposed to CB-153, we observed a significant increase in lymphocytic 
infiltration (+50%, p<0.05) in the livers and a significant (p<0.05) increase in tissue stress 
(+70%) in the thymus (Table 1). Thyroid follicles had larger cells, as shown by the 
significantly (p<0.05) increased ratio of follicular epithelium areas and number of nuclei 
(+36%) (Table 2). Testosterone levels were significantly increased in this group (Figure 1).  
In the animals exposed to TCDD we detected a significant (p<0.05) increase in 
lymphocytic infiltration (+50%, p<0.05) in the livers (Table 1); no significant changes were 
observed in the measured hormone levels; however, similar to HBCD and CB-153, a numeric 
increase of the T/E2 - ratio was observed (Figure 1).  
 
 
 
3.3 Differential protein and gene expression analysis  
We detected significant (p<0.01) quantitative differences in protein expression in the 
brains of the POP-exposed groups in comparison with controls, namely: (i) four proteins 
differentially expressed in brains of HBCD-exposed mice, (ii) four proteins in the CB-153 
exposed group, and (iii) 12 proteins in mice exposed to TCDD (Figure 2). Proteins 
reproduced successfully on preparative 2D gels were identified by LC-MS/MS (Figure 3). 
In addition to proteins displaying significant differences in expression level at the p<0.01 
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level we also identified a subset of proteins significant at p<0.05 to facilitate pathway 
analysis and to allow for validation of IPA predicted changes in the expression data set. To 
differentiate between the two sets, proteins significant at the p<0.01 level are marked with 
an asterisk (*). Relevant protein expression data including protein spot identifiers, statistical 
significance, fold changes, and protein identification features including accession number, 
isoelectric points, molecular weights, Mascot protein score and emPAI are presented in Table 
S2A and S2B. 
 
 
Further analysis of identified differentially expressed proteins revealed both unique and 
overlapping responses to the three pollutants (see Figure 4). Exposure to HBCD triggered 
unique abundance changes in heat shock 70kDa protein 8 (HSPA8; -1.29*), isovaleryl-CoA 
dehydrogenase, mitochondrial (IVD; -1.16*), mitogen-activated protein kinase 14 
(MAPK14; -1.26) and v-ral simian leukemia viral oncogene homolog A (ras related) (RALA; 
1.17*). Exposure to CB-153 elicited unique significant changes in dynamin 1 (DNM1; 1.39). 
Exposure to TCDD triggered unique significant changes in dihydropyrimidinase-related 
protein 3 (DPYSL3; 1.11), ATP synthase, H+ transporting, mitochondrial F1 complex, beta 
polypeptide (ATP5B; 1.16), alpha-enolase (ENO1; 1.15), actin, beta (ACTB; -1.21*) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1.28) Two proteins were observed to 
share significant changes in abundance after exposure to HBCD  and TCDD, respectively  
namely, NAD-dependent deacetylase sirtuin-2 (SIRT2; 1.13 and 1.27*) and  actin-related 
protein 2/3 complex subunit 2 (ARPC2; 1.18 and 1.18). Two proteins namely, tubulin beta-
2A chain (TUB2A; spot 415: -1.3  and -1.3 and spot 458: -1.14*) and glucose-6-
phosphate dehydrogenase (G6PD; -1.29*,-1.26*,-1.25*) had significantly altered expression 
levels after exposure to all three POP.    
 
In addition to exploratory proteomics analysis, we screened a total of 30 genes for 
differential expression levels in brain of mice exposed to the test compounds compared with 
the control (see Figure 5). The target genes, were chosen based on our previous data 
representing cellular pathways found to be affected by one or several of the three pollutants 
at higher doses [18] and from association with at least one of the toxicants in the Comparative 
Toxicogenomics Database (CTD) [42]. In accordance with the proteomics data, we screened 
for significantly differentially expressed genes at both the p<0.01 and p<0.05 level. To 
differentiate between the two sets, genes significant at the p<0.01 level are marked with an 
asterisk (*). Of the 30 genes tested, 4* and 7 (HBCD), 2* and 9 (CB-153) and 8* and 4 
(TCDD) displayed significant (p<0.01* and p<0.05) responses in gene expression. Gene 
expression data including p values, fold change, Entrez Gene Name, cellular location, 
function for all genes tested are presented in Table S3A. In addition, in Table S3A also the 
PubMed IDs of publications (as listed in the CTD) which reported differential regulation of 
the tested genes after exposure to HBCD, CB-153 and TCDD are provided.  
 
In accordance with the protein expression data, both unique and overlapping responses 
among treatments in all three-exposure conditions were detected in gene expression data (see 
Figure 4B). Substance-specific responses in gene expression concerned one gene for HBCD, 
(threonyl-tRNA synthetase-like 2, Tarsl2; -0.44*). Three genes were found to be 
dysregulated after exposure to CB-153, namely solute carrier family 30 (zinc transporter), 
member 3 (Slc30a3; -0.23), mitochondrial transcription termination factor 4 (Mterfd2; -1.23)  
tumor necrosis factor (ligand) superfamily, member 12 (Tnfsf12; ) and two genes for TCDD, 
namely nuclear receptor subfamily 1, group I, member 3 (Nr1i3; 1.42*),  DnaJ (Hsp40) 
homolog, subfamily B, member 5 (Dnajb5; 1.23). Differential expression of leucine zipper 
transcription factor-like 1 (Lztfl1) and aryl-hydrocarbon receptor nuclear translocator 2 
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(Arnt) was observed after exposure to either HBCD (Lztfl1: -0.64*; Arnt: -1.54) or CB-153 
(Lztfl1: -0.50; Arnt: -1.43). Differential expression of metal-regulatory transcription factor 1 
(Mtf1), NAD(P) dependent steroid dehydrogenase-like (Nsdhl), serine/arginine repetitive 
matrix 2 (Srrm2) and heat shock 70kDa protein 8 (Hspa8) was detected after exposure to 
either HBCD (Mtf1: 3.27; Nsdhl: 2.96; Srrm2: 2.90; Hspa8: 2.8) or TCDD (Mtf1: 1.97*; 
Nsdhl: 1.75*; Srrm2: 1.71*; Hspa8: 1.31). Differential expression of paroxysmal 
nonkinesigenic dyskinesia (Pnkd) and aryl hydrocarbon receptor nuclear translocator-like 
(Arntl) after exposure to either CB-153 (Pnkd: 0.88; Arntl: 0.643) or TCDD (Pnkd: 0.96*; 
Arntl: 0.71). The genes E2F-associated phosphoprotein (Eapp), eukaryotic translation 
initiation factor 5 (Eif5), sphingosine kinase 2 (Sphk2) and aryl hydrocarbon receptor (AhR) 
were found to be differential expressed after exposure to HBCD (Eapp: -1.25*; Eif5: -3.22*; 
Sphk2: 2.95; AhR: 2.75), CB-153 (Eapp: -1.09*; Eif5: -3.03*; Sphk2: 2.09; AhR: 1.97) or 
TCDD (Eapp: -1.07*; Eif5: -1.92*; Sphk2: 1.74 ; AhR: 1.67*). 
 
2.3 Proteomics functional analysis and bioinformatics  
The Ingenuity Pathway Analysis (IPA) platform was used with default settings to group 
proteins into larger functional categories (Table S4A–D). Similar to the differences observed 
in individual protein and gene expression induced by the three different POP, distinct and 
overlapping responses were detected at the pathway level (Figure 5). The functional 
categories “clathrin mediated endocytosis signalling” and “remodelling of epithelial adherens 
junctions” were significantly (p<0.05) affected by all three POP under investigation; “sertoli 
cell-sertoli cell junction signalling” and “sirtuin signalling” after exposure to HBCD and 
TCDD.  
  
 
To elucidate the early events upstream, the predicted effects on cellular and tissue 
biology of the juvenile brain, an “upstream regulator analysis” was performed in IPA. This 
analysis revealed that changes observed in the brain of mice exposed to HBCD and TCDD 
are linked to decreased ‘beta-estradiol’ (Figure 6A and 6B, respectively). No prediction could 
be made for CB-153.  
 
 
4. Discussion 
 
Risk assessment agencies call for data on the effects of direct exposure of children 
and infants to environmental contaminants including POP [28]. The diet, and oily fish in 
particular, represent a major route of exposure to HBCD, CB-153 and TCDD [43,44]. In the 
present study, using a fish based diet as vehicle, we describe systemic responses observed in 
juvenile female BALB/c mice after 28 days short-term repeated low-dose (LD) exposure to 
HBCD (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 bw-1) or TCDD (0.90 pg kg-1 bw 
day-1). In accordance with high-dose (HD) data we published earlier from this experiment in 
which mice were exposed to 199 mg HBCD kg-1 bw day-1), 195 μg CB-153 kg-1 bw day-1 
and 90 ng TCDD kg-1 bw day-1) [7,18], we put special attention on endocrine disruption, 
histopathologic and neurotoxicological effects in developing juvenile female BALB/c mice; 
a model appropriate for the study of early life dietary exposure [30].  
 
4.1 Histopathological findings and hormone measurements 
Histology data indicated that the thyroid displayed subtle alterations upon exposure to 
HBCD and CB-153 at both LD (present study) and HD [7] and upon exposure to TCCD at 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
HD exposure only [7]. The larger cells observed in thyroids of mice exposed to HBCD LD 
and CB-153 LD (present study) show that the thyroid is affected by HBCD and CB-153 at 
doses below the LOAELs previously established for juvenile mice [7]. As expected, 
structural changes were more evident at HD levels; and CB-153, a recognized inducer of 
thyroid toxicity [45], elicited effects at much lower exposure levels (both HD and LD) than 
HBCD. While POP-induced follicular cell hypertrophy can be reversed by a long-term 
withdrawal of POP exposure [46], early-onset and prolonged thyroid dysfunction can 
severely impact female reproductive health [47]. Both LD (present study) and HD exposure 
[7] to HBCD increased the incidence of marked vacuolation in hepatocytes; no such effect 
was observed after LD exposure to CB-153 or TCDD. This finding supports the hypothesis 
that lipid metabolism in liver is affected by HBCD in juvenile female mice [2]. The histology 
data indicated further that lymphocyte infiltration was increased in livers of mice after 
exposure to LD levels (present study) of HBCD, CB-153 or TCDD. At HD exposure livers 
of mice exposed to HBCD and CB-153 also displayed lymphocyte infiltration [7], whereas 
this change was absent in TCDD-treated mice. Lymphocyte infiltration suggests an ongoing 
persistent inflammation of the liver such as that observed in autoimmune hepatitis [48]. The 
increased occurrence of pyknotic nuclei, a hallmark of apoptosis [49], was not observed at 
LD (present study) whereas at HD was present only in livers of TCDD exposed mice [7]. 
These findings suggest that TCDD may induce different adverse effects in juvenile livers at 
different dose levels; direct hepatocyte toxicity, as evidenced by the increase of isolated 
necrotic hepatocytes (pyknotic nuclei) at HD, and chronic inflammation at LD exposure. The 
livers of HBCD LD exposed mice in the present study presented a noticeable association 
between hepatocyte vacuolation and chronic liver inflammation both features of non-
alcoholic fatty liver disease, a manifestation of the metabolic syndrome which is increasingly 
associated with exposures to environmental chemicals [50]. Our data thus highlights the need 
for further investigations on the hepatotoxic effects of POP such as HBCD at real-life 
exposure levels; the possible dose-dependency of TCDD-induced liver toxicity also deserves 
attention. 
The data we obtained on thymus indicates that the immune system of juvenile female 
mice may be a target of POP toxicity. Indeed, increased signs of tissue stress were observed 
in the thymus of mice exposed to all three contaminants tested at both LD (present study) and 
HD [7]. Interestingly, accelerated thymus regression can be related to sexual steroid stimulus 
[51]. In spleen histological changes were observed only at HD after exposure to CB-153 [7]. 
This indicates that spleen tissue may be less susceptible to POP exposure than thymus.  
Uterine histo-architecture showed a significantly decreased endometrial gland density 
upon exposure to LD HBCD (present study). Changes in circulating oestradiol 17β can 
modulate endometrial gland differentiation in mammals [52]. In fact, LD HBCD exposed 
mice showed a significant decrease in oestradiol 17β and a numerical decrease of testosterone 
concentration. In the previous HD study, HBCD induced only a numerical reduction of 
oestradiol while serum testosterone was significantly increased [7]. Ultimately, the T/E2 ratio 
was significantly increased at both LD (present study) and HD HBCD exposure [7].  
Data on the endocrine mode of action of HBCD are scarce. In in vitro experiments 
HBCD displayed both anti-androgenic and anti-oestrogenic activity in CALUXⓇ sex steroid 
receptor reporter gene assays and anti-oestrogenic activity in a MCF-7 cell proliferation assay 
[53,54]. Our data suggest that in vivo HBCD may elicit toxicologically relevant alterations 
of sex steroid balance at a dose below the LOAEL previously established for juvenile mice 
[7]. The T/E2 ratio upon TCDD exposure showed an apparent dose-related pattern, with a 
significant increase at HD [7] and a numerical, non-significant increase at LD (present study). 
Exposure to LD CB-153 significantly increased the serum testosterone levels and 
numerically increased the T/E2 ratio; at HD CB-153 exposure no difference from the control 
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groups was detected [7]; the possible relevance of this finding, e.g., with regard to a non-
monotonic dose-response relationship [55] warrant further investigation.  
4.2 Effects on murine brain gene and protein expression levels 
We assessed if exposure to the three contaminants HBCD, CB-153 and TCDD at LD 
induces differences in gene expression. Based on our previous work and genes of interest 
focusing on regulation of Ca2+ and Zn2+ selected from the CTD, a set of 30 target genes were 
analysed by qPCR. Of these 30 genes, eight (Ahr, Eapp, Eif5, Mtf1, Nr1i3, Nsdhl, Pnkd and 
Srm2), two (Eapp and Eif5) and four (Eapp, Eif5, Lztfl1 and Tarsl2) genes also were 
significantly differentially expressed after LD exposure to HBCD, CB-153 and TCDD, 
respectively. This confirmed that effects previously found to be affected at HD exposure were 
in parts reproducible in brains of mice exposed to doses below the LOAEL previously 
established in juvenile mice [7]. Moreover, these data highlight that already at LD exposure 
levels POP may interfere with the tightly controlled homeostasis of Ca2+ and Zn2+ in the 
juvenile brain.  
In addition to gene expression analysis, we performed a gel-based exploratory 
proteomics on brain tissue of POP exposed mice. Omics analyses allow for experiments 
which can implicate molecular networks affected by chemicals and help elucidating 
molecular initiating and key events in adverse outcome pathways [56]. Omics profiling is 
performed without prior hypothesis and is often considered as unbiased and discovery driven 
[3,57]. DIGE based proteomics analysis after exposure to HBCD, CB-153 and TCDD at the 
LD level (present study) induced dysregulation of three (HSPA8, G6PD and SIRT2), one 
(G6PD) and four (G6PD, TUB2A, ACTB and RALA) proteins, respectively. The protein, 
G6PD, was downregulated after LD exposure to all of the three POP. This is noteworthy 
because G6PD is a regulatory enzyme in the NADPH-dependent biotransformation of 
xenobiotics [58]. Its expression levels and activity determine the NADPH levels whose 
reductive power protects cells against reactive oxygen species (ROS)-induced oxidative 
stress damage [59]. Recently, a mechanistic link between increased G6PD activity, elevated 
NADPH and redox potential and improved antioxidant protection was established in 
transgenic mice with a modest overexpression of G6PD [59]. Conversely, a chemically 
induced G6PD reduction may thus increase the susceptibility to oxidative damage in the brain 
as was observed in G6PD deficient mice which displayed high levels of oxidative damage in 
the brain [60].  
The downregulation of G6PD protein, in the TCDD LD exposed mice, was accompanied 
by an upregulation of SIRT2 protein. This enzyme plays a key role in the dynamic regulation 
of G6PD helping cells to sense oxidative stress and to maintain NADPH homeostasis through 
G6PD acetylation in a SIRT2 dependent manner [61]. This finding provides further evidence 
that in cells in the brain are under at a least mild oxidative stress TCDD-exposed juvenile 
female BALB/c mice,  since SIRT2 is not up-regulated in unstressed cells [61]. Oxidative 
damage in the brain plays a key role in the functional decline of this organ system and 
predisposes it to vascular- and degenerative damage [62,63]. As early life exposure to POP 
affects learning and memory functions in adult mice [64], the dysregulation of oxidative 
stress sensors in the brains of a juvenile mouse model warrants further research. 
Besides oxidative stress related pathologies, G6PD deficiency was also highlighted to be 
a primary cause of decreased cholesterol anabolism and fatty acid β-oxidation; both of which 
are key to processes and functions such as plasma membrane formation, energy metabolism 
and cell signalling [65]. Fatty acid β-oxidation was recently demonstrated to be a target of 
HBCD toxicity; it was found to be downregulated in vitro in HepG2 cells and in vivo in livers 
of juvenile female BALB/c mice after exposure to t-HBCD and α-HBCD, respectively [2,66]. 
The observed effects on β-oxidation were hypothesised to occur via the suppression of 
PPAR-α through PXR-related pathways and/or the disruption of the otherwise tightly 
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controlled Ca2+ homeostasis [2]. G6PD mediated effects on β-oxidation could provide an 
additional explanation how POP exposure affects whole body lipid metabolism. 
In addition to enzymatic control via SIRT2, the expression levels and activity of G6PD 
were reported to be under hormonal control and increased in the presence of oestradiol 
[67,68]. A downregulation of G6PD, for example due to a POP induced altered T/E2 ratio 
may lead to a distinctly lower NADPH supply in the juvenile brain and consequently weaken 
its defences against oxidative stress and reduce fatty acid β-oxidation. The data obtained in 
the present study indicates that the observed downregulation of G6PD after LD exposure to 
HBCD, CB-153 and TCDD could, at least in part, be related to the significantly (HBCD and 
CB-153) and numerically (TCDD) increased T/E2 ratios. In addition, since the POP 
investigated in the present work were shown to pass the blood brain barrier (BBB) and to 
accumulate in the brain [18], further research could investigate if these xenobiotics might 
also interfere with the transformation between oestrogens and androgens directly in the brain.  
In vertebrates, T/E2 ratios are of great physiological importance and strongly affect the 
function of both reproductive and non-reproductive organs through various life stages [69]. 
Increased T/E2 ratios have been associated with metabolic changes such as hyperinsulinemia, 
impaired liver lipid metabolism and increased risk of cerebrovascular disease [70,71]. T/E2 
ratios are determined by the activity of the cytochrome P450 aromatase, a terminal enzyme 
expressed in various tissues of the body, which irreversibly transforms androgens into 
oestrogens [72,73]. In the brain, aromatase may play a pivotal role as it was shown that 
oestrogen is required for the maintenance, survival and the integrity of dopaminergic neurons 
[74,75]. Aromatization was also recently highlighted to be key for memory and learning in 
female organisms, which is mediated through both genomic and non-genomic actions of 
oestrogen [76]. Xenobiotics, which affect the conversion of oestrogen to testosterone and 
alter the T/E2 ratio, can therefore have a significant impact on brain health and disease [77].  
Aromatase was hypothesised to play an important role in the endocrine disruptive 
potential observed for HBCD, CB-153 and TCDD [10,78,79]. An in vitro study pointed out 
that already at femtomole exposure to TCDD significantly decreased E2 secretion and mRNA 
expression levels of aromatase were detected in human luteinizing granulosa cells [79]. 
Interestingly, similar to PPAR-α, which regulates β-oxidation, aromatase activity is also 
regulated by Ca2+, which strongly inhibits aromatase at high but still physiological 
concentrations [76]. HBCD, CB-153 and TCDD have previously been reported to disrupt 
Ca2+ homeostasis [12,18,80,81]. In a recent study our team further corroborated Ca2+ 
signalling a sensitive target of HBCD toxicity; in a parallel in vitro and in vivo 
transcriptomics study in juvenile mice and neuronal N2A and NSC19 cells. [3]. 
Bioinformatics analysis in the aforementioned study also implicated gene networks in the 
hypothalamus-hypophysis-gonadal axis and highlighted oestradiol 17β to be significantly 
regulated in mouse brain and both cells lines at both doses tested.     
Changes in Ca2+ homeostasis are also involved in the ageing of the brain and contribute 
to impaired cognition and increased vulnerability to excitotoxicity and neurodegenerative 
diseases; oestradiol may prevent those and offers neuroprotection even at advanced age [82]. 
In the present study, in addition to the observed altered serum T/E2 ratios, we observed 
significant differential down-regulation of HSPA8 and up-regulation of RALA after HBCD 
exposure and down-regulation of ACTB after TCCD exposure. In line with IPA knowledge 
base reports, which predict potentially affected upstream regulators from an expression data 
set, the downregulation of HSPA8 and ACTB and the upregulation of RALA were associated 
with decreases in oestradiol levels. When applying a less stringent significance cut-off for 
differential protein expression (p<0.05 instead of p<0.01), IPA analysis also allowed for the 
calculation of an activation z-score for oestradiol levels in the brain, which were predicted to 
be decreased after both HBCD LD and TCDD LD exposure.  
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Taken together, our findings indicate that the POP investigated may disrupt the T/E2 
balance in juvenile female mice through disruption of Ca2+ homeostasis. This leads to 
reduced G6PD expression and an associate reduced NADPH supply for xenobiotic 
detoxification and other cellular antioxidative defence mechanisms in the juvenile brain and 
increases its susceptibility to oxidative stress injury. In addition, reduced G6PD expression 
following POP exposure may also result in decreased cholesterol anabolism and impaired β-
oxidation in juvenile female BALB/c mice. 
 
4.3 Dose levels, environmental and human relevance 
In earlier work our team provided mechanistic data, which indicated known and novel 
targets of POP toxicity in postnatal development at doses close to published LOAELs in mice 
[3,7,18]. Having identified these targets in our study system, we wished to investigate if they 
are also affected at doses more relevant for human exposure during child- and early 
adulthood.  
Of the three chemicals investigated in the present study, the largest margin to human 
exposure levels was for HBCD. Dietary exposure to HBCD in European countries rarely 
exceeds 3 ng kg-1 bw d-1 [4], which is three orders of magnitude below the doses given to 
mice in the present study. Average daily dietary intakes in Europe of the sum of NDL PCB 
(PCB6) were reported to be in the range of 10–45 ng kg-1 bw d-1 for adults with limited 
exposure data for young children indicating that the average daily intake (breastfeeding 
excluded) of PCB6 is about 27–50 ng kg-1 bw [83]. Thus, the estimated average human 
exposure to CB-153 is approximately two orders of a magnitude lower than the one used in 
the present study (1.35 μg CB-153 kg-1 bw-1). However, high consumers of fatty fish may 
have intakes one order of magnitude higher than the median values of the population, as was 
established for a different POP group [84]. Thus, the exposure level of CB-153 in the present 
study may be considered to be in line with real-life intake of the 95th percentile consumers. 
The daily dose of TCDD mice were exposed to in the present study (0.90 pg kg-1 bw-1) is 
similar to the average sum of dioxins and DL PCB exposure between 1.08 and 2.54 pg 
WHO05-TEQ kg
-1 bw estimated in European toddlers and other children [85]. 
Conclusions 
In the present study, for the first time it has been shown that exposure to HBCD, CB-
153, or TCDD through a fish-based diet is associated with subtle, but toxicological relevant 
aberrations in histology, endocrinology, protein expression, and gene regulation at doses 
below the LOAEL previously established in juvenile female mice [7,18]. While the observed 
effects were not severe their occurrence before the start of sexual maturity should not be 
overlooked as disruptions during critical phases of development and maturation may in the 
long term alter the ability of the organism to cope with external stimuli, pregnancy or aging.    
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Figure 1. Testosterone (T) and 17β–oestradiol (E2) levels and T to E2 ratios (T/E2) 
in serum samples of juvenile female Balb/c mice after 28 days of repeated dietary 
exposure to HBCD  (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 bw-1 day-1) and 
TCDD (0.90 pg kg-1 bw-1 day-1), respectively. Data are presented as mean ± standard 
deviation. Statistical significance (one-way ANOVA, n=10) is indicated by an 
asterisks sign (*).  
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Figure 2. Proteomic responses detected in brains of  BALB/c mice after 28 days of 
repeated dietary exposure exposed to HBCD (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 
μg kg-1 bw-1 day-1) or TCDD (0.90 pg kg-1 bw-1 day-1). Volcano plots show the 
calculated statistical significance on the y axis (expressed as −log10 p value) versus 
the estimated fold change on the x axis (expressed as ± log 2 fold change). Red dots 
represent differentially regulated proteins (p < 0.05); proteins differentially 
regulated at the p<0.01 level are highlighted with an asterisk (*). Red dots with black 
crosses represent the top ranked proteins, which have been identified successfully 
by LC–MS/MS. The numbers in the plots describe the unique protein spot 
identifiers. See Table S2A for further details on individual proteins. 
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Figure 3. Preparative two-dimensional (2D) gel showing the picked and 
successfully identified significantly regulated (p < 0.01, ANOVA, n=18) proteins in 
brain of juvenile female BALB/c mice after 28 days of repeated dietary exposure 
exposed to HBCD (49.5 μg kg-1 bw-1 day-1 day-1), CB-153 (1.35 μg kg-1 bw-1 day-1) 
or TCDD (0.90 pg kg-1 bw-1 day-1). Proteins differentially regulated at the p<0.01 
level are highlighted with an asterisk (*). The numbers in the plot describe the 
unique difference in gel protein spot identifiers. The location of the spots relative to 
the x and y axes of the plot reflects the approximate isoelectric points and relative 
molecular weights, respectively of the detected protein spots. See Table S2B for 
further details on individual proteins. 
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Figure 5.  Heatmaps of differentially expressed proteins (A) and genes (B) in brain 
of juvenile female BALB/c mice after 28 days of repeated dietary exposure exposed 
to HBCD (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 bw-1 day-1) or TCDD (0.90 
pg kg-1 bw-1 day-1). A: Protein names are provided alongside their unique 2D gel 
spot identifiers (MS) and gene symbol identifiers. Statistical significance is 
indicated by one asterisk sign (*) for the p<0.05 level and two asterisks signs (**) 
for the p<0.01 level. B: HD and CTD displays genes which according to literature 
were found to be differentially expressed after high dose exposure to high dose (HD) 
HBCD, CB-153 and TCDD. One plus (+) sign indicates listing in the Comparative 
Toxicogenomics Database (CTD) [42]; two plus signs (++) that these genes were 
also found to be differentially expressed in HD exposure to HBCD, CB-153 and 
TCDD [18]. LD displays genes which were found to be differentially expressed in 
the present study. Statistical significance is indicated by one asterisk sign (*) for the 
p<0.05 level and two asterisks signs (**) for the p<0.01 level. Yellow and blue boxes 
indicate up- and down regulation, respectively and the “global” bar at the bottom 
indicates the the upper and lower limits of the colour gradient. Additional data for 
all genes tested are presented in Table S3A. Blue and yellow boxes indicate up- and 
down regulation, respectively. Additional data for all proteins tested are presented 
in Table S3A. 
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Figure 5. Ingenuity Pathway Analysis (IPA). Significantly regulated (p < 0.05) 
proteins in brain of juvenile female BALB/c mice after 28 days of repeated dietary 
exposure exposed to HBCD  (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 bw-1 
day-1) or TCDD (0.90 pg kg-1 bw-1 day-1) were grouped according to IPA “canonical 
pathways”. In addition, over-representation of detected proteins in different 
“canonical pathways” was determined and is shown as a heatmap. Only selected 
pathways that were significantly (p < 0.05, Fisher’s exact test) enriched in at least 
one of the exposure conditions are shown alongside their significance values 
expressed as scores (−log10 p-value). Scores above the cut-off (1.3) are displayed 
by a green to red colour gradient. Scores below the cut-off value are displayed as 
grey boxes. The full data-set including the proteins in each pathway is presented in 
Table S4A (proteins).  
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Figure 6. Ingenuity Pathway Analysis (IPA) of “upstream regulators”. Significantly 
regulated (p < 0.05, ANOVA) proteins in brain of juvenile female BALB/c mice 
after 28 days of repeated dietary exposure exposed to HBCD (49.5 μg kg-1 bw-1 day-
1), CB-153 (1.35 μg kg-1 bw-1 day-1) or TCDD (0.90 pg kg-1 bw-1 day-1) were 
subjected to IPA. Changes observed in the brain of mice exposed to HBCD (A) and 
TCDD (B) are linked to decreased beta-estradiol levels. Activation (displayed in 
yellow) and inhibition (displayed in blue) of regulators and functions are based on 
IPA activation z-scores, which combine directional information encoded in the 
protein expression results with knowledge from the literature to make predictions 
about likely adverse outcome pathways. Up-regulated proteins are coloured red, 
down-regulated proteins are coloured green. The full data-sets of the upstream 
regulator analysis and the diseases and biological functions are presented in Table 
S4D. 
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Table 1. Histological evaluation of potential target tissues of persistent organic 
pollutant (POP) toxicity in juvenile female BALB/c mice after 28 days of repeated 
dietary exposure to HBCD (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 bw-1 day-
1) or TCDD (0.90 pg kg-1 bw-1 day-1), respectively. Statistically significant 
differences in the categorical data obtained were elucidated by two tailed Fisher’s 
Exact Tests. Significant effects at the p<0.05 levels, are indicated by an asterisks 
sign (*). 
Tissue Observations Group 
  Control HBCD CB-153 TCDD 
Thyroid 
Desquamation into 
follicular lumen 
0/7  3/7 2/7 0/7 
Foaming colloid 1/7 2/7 4/7 3/7 
Uterus 
Irregular 
multistratification 
of the luminal 
epithelium 
1/8 2/7 3/9 4/6 
Reduction in 
endometrial 
glands density 
0/8 4/7* 2/9 2/6 
Liver 
Marked vacuolization 
in hepatocytes 
0/10 5/8* 1/8 2/8 
Lymphocytic 
infiltration 
0/10 6/8* 4/8* 4/8 * 
Hyperaemic vessels 0/10 6/8* 0/8 1/8 
Picnotic nucleus 0/10 2/8 2/8 2/8 
Adrenals 
Thickness external 
capsule 
2/10 3/7 2/9 3/8 
Thymus 
Hassal’s bodies 2/10 5/10 4/10 2/10 
Cortical invasivity 2/10 2/10 4/10 2/10 
Minerals 2/10 5/10 0/10 6/10 
Stress 0/10 5/10* 7/10* 0/10 
Spleen 
Lymphocyte 
hyperplasia 
4/10 5/10 2/10 6/10 
Infiltration in red pulp 
and 
periarteriolar zones 
(PALS) 
0/10 0/10 2/10 0/10 
Brain 
Eosinophilic cells in 
the cortex 
2/10 3/8 4/9 4/10 
Eosinophilic cells in 
the thalamus 
3/10 2/8 4/9 0/10 
Condensed cells in the 
hypothalamus 
0/10 1/8 0/9 0/10 
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Table 2. Histomorphological evaluation of potential target tissues of persistent 
organic pollutant (POP) toxicity in juvenile female BALB/c mice after 28 days of 
repeated dietary exposure to HBCD (49.5 μg kg-1 bw-1 day-1), CB-153 (1.35 μg kg-1 
bw-1 day-1) or TCDD (0.90 pg kg-1 bw-1 day-1), respectively. Statistically significant 
differences in the categorical data obtained were elucidated by two tailed Mann-
Whitney U Test. Significant effects at the p<0.05 levels, are indicated by an asterisks 
sign (*). 
Tissue Measures Group 
  Control HBCD CB-153 TCDD 
Thyroid 
 n=5 n=5 n=5 n=5 
Ratio between follicle 
and colloid areas 
1.41 ± 
0.07 
1.46 ± 
0.10 
1.51 ± 
0.13 
1.52 ± 
0.09 
Follicle area (μm2) 
2402 ± 
500 
1691 ± 
608 
1830 ± 
754 
1435 ± 
256 
Colloid area (μm2) 
1718 ± 
403 
1190 ± 
535 
1251 ± 
590 
953 ± 
202 
Ratio of follicular 
epithelium areas and 
number of nuclei 
2.14 ± 
0.09 
2.57 ± 
0.27* 
2.91 ± 
0.74* 
2.66 ± 
0.41 
Uterus 
 n=8 n=7 n=8 n=6 
Ratio between area of 
endometrium and 
myometrium 
4.07 ± 
1.18 
4,82 ± 
1.14 
4,30 ± 
1.17 
3,61 ± 
1.56 
Adrenals 
 n = 8 n=5 n=5 n=4 
Ratio between cortex 
and medulla areas 
5.50 ± 
1.59 
7,44 ± 
1.49 
7,91 ± 
3.96 
5,65 ± 
2.21 
Thymus 
 n=6 n=8 n=7 n=7 
Ratio between cortex 
and medulla areas 
2.55 ± 
0.77 
2,64 ± 
1.18 
3,75 ± 
1.88 
3,39 ± 
0.91 
Spleen 
 n=8 n=10 n=10 n=7 
Ratio between red 
pulp and white pulp 
areas 
2.54 ± 
0.85 
1,00 ± 
0.30 
1,40 ± 
0.34 
3,32 ± 
1.75 
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